Henry Ford Cancer Center

Detroit, Michigan 48242

4 studies enrolling now · 5 studies all time

What they study most

Hemoglobinopathy, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Nasopharyngeal Cancer Recurrent, Sickle Cell Disease

Studies at this site

• A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer — Recruiting now
• Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors — Recruiting now
• A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) — Recruiting now
• A Long-term Follow-up Study in Patients Who Received BEAM-101 — Recruiting now
• BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease — Running, not enrolling